Recruiting Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study NCT06805812 Conditions Abemaciclib, Breast Adenocarcinoma, Breast Cancer, +46 more Locations Centro di Riferimento Oncologico IRCCS — Aviano, Italy Azienda Socio Sanitaria Territoriale degli Spedali Civili — Brescia, Italy Humanitas Istituto Clinico Catanese — Catania, Italy ASST Lariana - Ospedale Sant'Anna — Como, Italy View all 24 locations View more locations Show fewer locations Loading locations... View Trial Details
Active, Not Recruiting Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies NCT04561362 Conditions Adnexal Diseases, Advanced Solid Tumor, Breast Diseases, +30 more Locations Sarah Cannon Research Institute at HealthONE — Denver, Colorado, United States Ocala Oncology Center — Ocala, Florida, United States Advent Health — Orlando, Florida, United States Icahn School of Medicine at Mount Sinai — New York, United States View all 24 locations View more locations Show fewer locations Loading locations... View Trial Details
